Moreover, the increased concentrations of various pro-inflammatory mediators such as CCL4, CCL17, CCL28, CXCL5, CXCL10, and CX3CL1 in the blood of AD patients might contribute to the formation of atherosclerotic plaques [162]. Here, CCL17 is linked to Alzheimer disease.